78
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      BRACHYURY and CDX2 Mediate BMP-Induced Differentiation of Human and Mouse Pluripotent Stem Cells into Embryonic and Extraembryonic Lineages

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          BMP is thought to induce hESC differentiation toward multiple lineages including mesoderm and trophoblast. The BMP-induced trophoblast phenotype is a long-standing paradox in stem cell biology. Here we readdressed BMP function in hESCs and mouse epiblast-derived cells. We found that BMP4 cooperates with FGF2 (via ERK) to induce mesoderm and to inhibit endoderm differentiation. These conditions induced cells with high levels of BRACHYURY (BRA) that coexpressed CDX2. BRA was necessary for and preceded CDX2 expression; both genes were essential for expression not only of mesodermal genes but also of trophoblast-associated genes. Maximal expression of the latter was seen in the absence of FGF but these cells coexpressed mesodermal genes and moreover they differed in cell surface and epigenetic properties from placental trophoblast. We conclude that BMP induces human and mouse pluripotent stem cells primarily to form mesoderm, rather than trophoblast, acting through BRA and CDX2.

          Abstract

          Graphical Abstract

          Highlights

          ► BMP+FGF induces ESCs to express BRA hi/CDX2 + while Activin+FGF induces BRA low/SOX17 + ► BRA and CDX2 are required for mesoderm- and trophoblast-associated gene expression ► Epigenetic and surface features discern BMP-treated hESCs from in vivo trophoblast ► BMP-treated hESCs expressing trophoblast-associated genes coexpress mesoderm genes

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.

          The potential to generate virtually any differentiated cell type from embryonic stem cells (ESCs) offers the possibility to establish new models of mammalian development and to create new sources of cells for regenerative medicine. To realize this potential, it is essential to be able to control ESC differentiation and to direct the development of these cells along specific pathways. Embryology has offered important insights into key pathways regulating ESC differentiation, resulting in advances in modeling gastrulation in culture and in the efficient induction of endoderm, mesoderm, and ectoderm and many of their downstream derivatives. This has led to the identification of new multipotential progenitors for the hematopoietic, neural, and cardiovascular lineages and to the development of protocols for the efficient generation of a broad spectrum of cell types including hematopoietic cells, cardiomyocytes, oligodendrocytes, dopamine neurons, and immature pancreatic beta cells. The next challenge will be to demonstrate the functional utility of these cells, both in vitro and in preclinical models of human disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.

            Bone morphogenetic protein-4 (BMP-4) is a member of the TGF-beta superfamily of polypeptide signaling molecules, closely related to BMP-2 and to Drosophila decapentaplegic (DPP). To elucidate the role of BMP-4 in mouse development the gene has been inactivated by homologous recombination in ES cells. Homozygous mutant Bmp-4tm1blh embryos die between 6.5 and 9.5 days p.c., with a variable phenotype. Most Bmp-4tm1blh embryos do not proceed beyond the egg cylinder stage, do not express the mesodermal marker T(Brachyury), and show little or no mesodermal differentiation. Some homozygous mutants develop to the head fold or beating heart/early somite stage or beyond. However, they are developmentally retarded and have truncated or disorganized posterior structures and a reduction in extraembryonic mesoderm, including blood islands. These results provide direct genetic evidence that BMP-4 is essential for several different processes in early mouse development, beginning with gastrulation and mesoderm formation. Moreover, in the presumed absence of zygotic ligand, it appears that homozygous mutants can be rescued partially by related proteins or by maternal BMP-4.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

              Maintenance of pluripotency is crucial to the mammalian embryo's ability to generate the extra-embryonic and embryonic tissues that are needed for intrauterine survival and foetal development. The recent establishment of embryonic stem cells from human blastocysts (hESCs) provides an opportunity to identify the factors supporting pluripotency at early stages of human development. Using this in vitro model, we have recently shown that Nodal can block neuronal differentiation, suggesting that TGFbeta family members are involved in cell fate decisions of hESCs, including preservation of their pluripotency. Here, we report that Activin/Nodal signalling through Smad2/3 activation is necessary to maintain the pluripotent status of hESCs. Inhibition of Activin/Nodal signalling by follistatin and by overexpression of Lefty or Cerberus-Short, or by the Activin receptor inhibitor SB431542, precipitates hESC differentiation. Nevertheless, neither Nodal nor Activin is sufficient to sustain long-term hESC growth in a chemically defined medium without serum. Recent studies have shown that FGF2 can also maintain long-term expression of pluripotency markers, and we find that inhibition of the FGF signalling pathway by the tyrosine kinase inhibitor SU5402 causes hESC differentiation. However, this effect of FGF on hESC pluripotency depends on Activin/Nodal signalling, because it is blocked by SB431542. Finally, long-term maintenance of in-vitro pluripotency can be achieved with a combination of Activin or Nodal plus FGF2 in the absence of feeder-cell layers, conditioned medium or Serum Replacer. These findings suggest that the Activin/Nodal pathway maintains pluripotency through mechanism(s) in which FGF acts as a competence factor and therefore provide further evidence of distinct mechanisms for preservation of pluripotency in mouse and human ESCs.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell Stem Cell
                Cell Stem Cell
                Cell Stem Cell
                Cell Press
                1934-5909
                1875-9777
                05 August 2011
                05 August 2011
                : 9
                : 2
                : 144-155
                Affiliations
                [1 ]The Anne McLaren Laboratory for Regenerative Medicine, University of Cambridge, Cambridge CB2 0SZ, UK
                [2 ]Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK
                [3 ]Laboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge CB22 3AT, UK
                [4 ]MRC National Institute for Medical Research, Mill Hill, London NW7 1AA, UK
                [5 ]Department of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA
                [6 ]Centre for Trophoblast Research, University of Cambridge, Cambridge CB2 3EG, UK
                [7 ]Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK
                [8 ]Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK
                [9 ]Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK
                Author notes
                []Corresponding author asb63@ 123456cam.ac.uk
                [∗∗ ]Corresponding author ralp2@ 123456cam.ac.uk
                Article
                STEM960
                10.1016/j.stem.2011.06.015
                3567433
                21816365
                6088c3a6-3ed3-438e-a6c8-4ccceeaf0b99
                © 2011 ELL & Excerpta Medica.

                This document may be redistributed and reused, subject to certain conditions.

                History
                : 11 October 2010
                : 14 April 2011
                : 30 June 2011
                Categories
                Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article